At the European Parliament’s plenary session on Tuesday, MEPs adopted the Parliament’s position on critical medicines. Viktória Ferenc, MEP for Fidesz–KDNP and member of the Patriots for Europe Group, welcomed the decision, stressing that the vote sends a clear political message: Europe must strengthen its own pharmaceutical supply and industrial capacities.

In her speech, the MEP pointed out that misguided decisions in recent years and the vulnerability of global supply chains have left Europe exposed in the field of strategically important medicines. “Patient safety can only be guaranteed if we strengthen production in Europe, support investments, and act through concrete decisions rather than slogans,” she said.

Viktória Ferenc emphasized that the security of pharmaceutical supply cannot be ensured through excessive or ideological regulation. Europe’s pharmaceutical industry needs reasonable, proportionate and predictable environmental and industrial rules that protect the environment, guarantee supply for citizens and strengthen the sector’s competitiveness.

The MEP also recalled that Hungary ranks third in the European Union in terms of GDP-proportionate corporate pharmaceutical research and development spending. “The key to Europe’s supply security lies in recognising and protecting strong and innovative national pharmaceutical hubs such as Hungary,” she emphasised.

“Europe can only protect its patients if it relies on its own industry, reduces bureaucracy, and puts common sense ahead of ideologies. We welcome the fact that Commissioner Olivér Várhelyi has come forward with a legislative proposal built on these principles, which the European Parliament can further strengthen. In this work, Fidesz will continue to stand consistently for the safety of European citizens,” he added after the vote.